CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

There’s Always Evidence…

January 19, 2021 - February 9, 2021
There’s solid agreement that decisions in health care that are informed by hard facts are likely to be better than decisions made based on gut instinct or something your brother’s best friend’s second cousin says his grandmother’s neighbour told him. Systematic reviews and meta-analyses are regarded as the gold standard for evidence, but they ar...

How CADTH Expert Committees Deliberate

February 4, 2021
CADTH has three expert committees that provide recommendations to publicly funded drug programs, health ministries, and health authorities on the appropriate use of drugs, medical devices, and clinical interventions: CADTH pan-Canadian Oncology Drug Review Expert Review Committee (pERC): cancer drugs CADTH Canadian Drug Expert Committee (CDE...

Consultation for Patients on the Deliberative Appraisal Process at CADTH

February 11, 2021
The top three principles for the deliberative process identified by the Health Technology Assessment International 2020 Global Policy Forum were transparency, inclusivity, and impartiality. CADTH has worked with a few patient groups to create a two-part consultation to support wide participation: first, an education session — How CADTH Expert C...